Target Group (OTCQB: CBDY) has named Azmatali Mehrali as the company’s new chief financial officer.
The company is “calibrating the leadership of its finance department” in a bid to optimize and accelerate its international and domestic initiatives, the company said in a statement.
Mehrali will be responsible for Target’s finance department, with a focus on capital allocation planning, M&A, and transactional execution, according to the company.
The appointment is effective June 14.
Mehrali’s Experience
More recently, Mehrali has provided consulting services to medicinal cannabis start-ups across North America, particularly in Canada as they prepare for public listing. He has over 30 years of financial services experience, serving as CFO for several firms including Wells Fargo Canada Securities, Brookfield Securities, and Virtual Brokers.
Since 2006, he has served as president of a private CFO consulting business that provides regulatory and financial services to start-up brokerage firms in Canada.
In addition, Mehrali served as vice president, finance at Genuity Capital Markets, assistant controller at Investment Technology Group Canada, and director of finance at CIBC World Markets.
“Mr. Mehrali brings a wealth of transactional experience, strategic leadership and financial expertise to our management lineup, and will provide complimentary experience to our already robust finance team”, Target CEO Rubin Schindermann stated.
“His addition will assist in ensuring the Company is suitably positioned to capitalize on available growth opportunities as we expand our portfolio of cannabis brands throughout 2019-2020,” Schindermann added.
Target Group is a vertically integrated cannabis acquisition company which owns and operates Canary Rx, a final-stage Canadian cannabis license applicant, and CannaKorp, makers of the pod-based Wisp Vapor technology. The company is expanding its global operations to build an international network of manufacturing, distribution, production, and sales operations.